Aelius Biotech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $971K

  • Investors
  • 6

Aelius Biotech General Information

Description

Developer of a model gut system intended to help healthcare industry participants simulate digestion, mucus permeation, and epithelial absorption. The company offers a range of in vitro testing and in vivo testing, simple lab assays and routine testing, rheology, integrated model gut testing through the aerodigestive tract, and also runs human trials, enabling healthcare companies to make data-driven decisions to drive and develop and de-risk orally delivered products in development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12 Blandford Square
  • Newcastle upon Tyne NE1 4HZ
  • England, United Kingdom
+44 07309
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 12 Blandford Square
  • Newcastle upon Tyne NE1 4HZ
  • England, United Kingdom
+44 07309

Aelius Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aelius Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 07-Apr-2025 $971K Completed Generating Revenue
3. Later Stage VC 23-Nov-2023 Completed Generating Revenue
2. Grant 01-Apr-2022 $272K Completed Startup
1. University Spin-Out 24-Aug-2018 Completed Startup
To view Aelius Biotech’s complete valuation and funding history, request access »

Aelius Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
To view Aelius Biotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aelius Biotech Patents

Aelius Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023391264-A1 Biological modelling device Pending 07-Dec-2022
EP-4630532-A1 Biological modelling device Pending 07-Dec-2022
GB-202218384-D0 Biological modelling device Inactive 07-Dec-2022
GB-2625116-A Biological modelling device Inactive 07-Dec-2022
WO-2024121557-A1 Biological modelling device Inactive 07-Dec-2022 C12M23/12
To view Aelius Biotech’s complete patent history, request access »

Aelius Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aelius Biotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Regional Development Fund (Brandenburg) Government Minority
Mercia Ventures Venture Capital Minority
NEDFi Venture Capital Venture Capital Minority
North East Fund Venture Capital Minority
Innovate UK Government
You’re viewing 5 of 6 investors. Get the full list »

Aelius Biotech Investments (1)

Aelius Biotech’s most recent deal was a Seed Round with MarraBio for . The deal was made on 18-Sep-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MarraBio 18-Sep-2023 Seed Round Biotechnology
To view Aelius Biotech’s complete investments history, request access »

Aelius Biotech FAQs

  • When was Aelius Biotech founded?

    Aelius Biotech was founded in 2018.

  • Where is Aelius Biotech headquartered?

    Aelius Biotech is headquartered in Newcastle upon Tyne, United Kingdom.

  • What is the size of Aelius Biotech?

    Aelius Biotech has 16 total employees.

  • What industry is Aelius Biotech in?

    Aelius Biotech’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Aelius Biotech a private or public company?

    Aelius Biotech is a Private company.

  • What is Aelius Biotech’s current revenue?

    The current revenue for Aelius Biotech is .

  • How much funding has Aelius Biotech raised over time?

    Aelius Biotech has raised $2.51M.

  • Who are Aelius Biotech’s investors?

    European Regional Development Fund (Brandenburg), Mercia Ventures, NEDFi Venture Capital, North East Fund, and Innovate UK are 5 of 6 investors who have invested in Aelius Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process